OBLN Insider Trading Activity and SEC Form 4 Filings
OBLN insider trading summary
No open-market insider purchases or sales of Obalon Therapeutics Inc (OBLN) have been reported on SEC Form 4 in the past 12 months.
Latest OBLN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 12, 2019 | William J. Plovanic | President & CEO | Buy | $108K (65,000 @ $1.66) |
| Aug 6, 2019 | InterWest Management Partners X, LLC | 10% Owner | Buy | $100K (25,000 @ $4.00) |
| Aug 6, 2019 | Jesse I Treu | 10% Owner | Buy | $1.0M (250,000 @ $4.00) |
| Aug 6, 2019 | Arnold L Oronsky | 10% Owner | Buy | $100K (25,000 @ $4.00) |
| Aug 6, 2019 | Keval Desai | 10% Owner | Buy | $100K (25,000 @ $4.00) |
| Aug 6, 2019 | Mark Brister | Chief Technology Officer | Buy | $20K (5,000 @ $4.00) |
| Aug 6, 2019 | Gilbert H Kliman | 10% Owner | Buy | $100K (25,000 @ $4.00) |
| Aug 6, 2019 | Nicole Vitullo | 10% Owner | Buy | $1.0M (250,000 @ $4.00) |
| Aug 6, 2019 | Brian K Halak | 10% Owner | Buy | $1.0M (250,000 @ $4.00) |
| Aug 6, 2019 | Lesley H Howe | Insider | Buy | $25K (6,250 @ $4.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.